
Last Price
52 Week Range
$4.24 - $14.39
Next Earnings Date
-
Next Earnings Date
-
Last Price
Company Name | Form Type | Filed | View |
|---|---|---|---|
Trevi Therapeutics, Inc. | 10-Q | May 5, 2026 | |
Trevi Therapeutics, Inc. | 8-K | May 5, 2026 | |
Trevi Therapeutics, Inc. | ARS | April 21, 2026 | |
Trevi Therapeutics, Inc. | DEFA14A | April 21, 2026 | |
Trevi Therapeutics, Inc. | DEF 14A | April 21, 2026 | |
Trevi Therapeutics, Inc. | 8-K | April 17, 2026 | |
Trevi Therapeutics, Inc. | PRE 14A | April 10, 2026 | |
Trevi Therapeutics, Inc. | 10-K | March 17, 2026 | |
Trevi Therapeutics, Inc. | 8-K | March 17, 2026 | |
Trevi Therapeutics, Inc. | 8-K | March 9, 2026 | |
Trevi Therapeutics, Inc. | 8-K | December 5, 2025 | |
Trevi Therapeutics, Inc. | 8-K | November 13, 2025 | |
Trevi Therapeutics, Inc. | S3ASR | November 13, 2025 | |
Trevi Therapeutics, Inc. | 10-Q | November 13, 2025 | |
Trevi Therapeutics, Inc. | 8-K | August 20, 2025 | |
Trevi Therapeutics, Inc. | 8-K | August 7, 2025 | |
Trevi Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 17, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 4, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 2, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 2, 2025 | |
Trevi Therapeutics, Inc. | 10-Q | May 8, 2025 | |
Trevi Therapeutics, Inc. | 8-K | May 8, 2025 | |
Trevi Therapeutics, Inc. | DEF 14A | April 29, 2025 | |
Trevi Therapeutics, Inc. | ARS | April 29, 2025 | |
Trevi Therapeutics, Inc. | DEFA14A | April 29, 2025 | |
Trevi Therapeutics, Inc. | 8-K | March 18, 2025 | |
Trevi Therapeutics, Inc. | 10-K | March 18, 2025 | |
Trevi Therapeutics, Inc. | 8-K | March 10, 2025 | |
Trevi Therapeutics, Inc. | 8-K | January 8, 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers